FIELD: medicine.
SUBSTANCE: composition for prevention of diseases caused by CMV infection contains inactivated suspension of Human herpesvirus 5 ATCC® VR-1788™, polioksidony, hyaluronic acid, glycyrrhizic acid in an effective amount.
EFFECT: increased efficiency of treatment of diseases caused by CMV.
3 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING TEST-SYSTEM FOR DIAGNOSTICS OF CYTOMEGALOVIRUS INFECTION BY METHOD OF IMMUNOBLOTTING | 2013 |
|
RU2545785C2 |
METHOD FOR PREPARING IMMUNOSORBENT FOR DIAGNOSING HERPES SIMPLEX TYPE I | 2013 |
|
RU2528896C1 |
TEST SYSTEM FOR SIMULTANEOUS DETECTION OF HUMORAL MARKERS OF HUMAN HERPES VIRUS INFECTION | 2019 |
|
RU2724897C1 |
REAGENT KIT FOR DETECTION OF SARS-COV-2 VIRUS RNA BY REAL-TIMR POLYMERASE CHAIN REACTION | 2022 |
|
RU2795939C2 |
ECHINACEA TINCTURE AND METHOD FOR PRODUCING ECHINACEA TINCTURE | 2015 |
|
RU2567035C2 |
METHOD OF SIMULTANEOUS DETECTION OF ANTIBODIES OF CLASS G TO ANTIGENS OF AGENTS OF TORCH-INFECTIONS USING IMMUNOCHIP | 2014 |
|
RU2545792C2 |
ECHINACEA PURPUREA TINCTURE AND METHOD OF PRODUCING SAME | 2014 |
|
RU2552919C2 |
STABILIZED CARDIOLYPINE ANTIGEN FOR THE REACTION OF MICROPRECIPITATION WITH SYPHILISIS DIAGNOSIS AND THE METHOD OF ITS RECEPTION | 2016 |
|
RU2633087C2 |
TINCTURE OF THE DRONE BROOD AND THE METHOD OF ITS OBTAINING | 2017 |
|
RU2690516C2 |
HERBAL MEDICINAL LIQUEUR AND METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2722067C2 |
Authors
Dates
2017-04-13—Published
2015-12-29—Filed